Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sabrina Graß
NSCLC: Zwei Positive Studien Zu PD-L1-Hemmer
Im Focus Onkologie
Related publications
PD-L1-Hemmer Bei Vorbehandelten Patienten Mit NSCLC
Im Focus Onkologie
NSCLC: Atezolizumab Mit Überlebensvorteil Unabhängig Vom PD-L1-Status
Pneumologie
Medicine
Pulmonary
Respiratory Medicine
MA09.09 EBUS-TBNA in Assessing PD-L1 Expression in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Pembro Ups Survival in PD-L1–positive HNSCC
Cancer Discovery
Oncology
Atezolizumab Combo Approved for PD-L1–positive TNBC
Cancer Discovery
Oncology
45. A Retrospective Assessment of PD-L1 Expression Rates in NSCLC
Pathology
Forensic Medicine
Pathology
PD-L1-Antikörper Durvalumab Verlängert Überleben Bei NSCLC Im Stadium III
Pneumologie
Medicine
Pulmonary
Respiratory Medicine
P2.04-05 Correlation Between PD-L1 Gene Promoter Polymorphisms and Expression of PD-L1 mRNA and Protein in NSCLC Patients.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P057 Pembrolizumab + Chemo vs Chemo Alone as First Line Treatment in PD-L1 Positive Advanced NSCLC: A Meta-Analysis
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary